Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. prostatectomy
Show results for
Products
Services

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Prostatectomy Articles & Analysis

15 news found

Bayer expands global clinical program for darolutamide in prostate cancer

Bayer expands global clinical program for darolutamide in prostate cancer

Current treatment options for patients with biochemical recurrent prostate cancer include prostatectomy, intending to be curative. If these treatments are unsuccessful, androgen deprivation therapy (ADT) is an option to control disease.2 About darolutamide (Nubeqa) Darolutamide is an oral androgen receptor inhibitor (ARi) with a distinct chemical structure that binds to the ...

ByBayer AG


How Technology, Early Diagnoses Can Help Turn the Tide on Prostate Cancer Prognosis

How Technology, Early Diagnoses Can Help Turn the Tide on Prostate Cancer Prognosis

Further, PSMA PET detects far more prostate lesions than Fluciclovine PET in men who experienced a cancer recurrence after undergoing radical prostatectomy. Combining 3-D Ultrasound And MRI For Less Ambiguity Advancements in technology can now give a medical team a real-time view of the prostate through a guided 3-D ultrasound. ...

ByLifespin GmbH


I Lost One of the Most Vital Organs - Prostate Cancer Patient Stories

I Lost One of the Most Vital Organs - Prostate Cancer Patient Stories

Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...

ByProUroCare Medical Inc.


Integrating Fusion Biopsies into Your Practice I

Integrating Fusion Biopsies into Your Practice I

On average, about 64% of the positive fusion biopsy cases were followed by radical prostatectomy. Depending on the type of treatment and place of service, clinics could earn an additional $208k from treating just 20 more patients. ...

ByFocal Healthcare


First Dexter surgeries in urology carried out in Bern

First Dexter surgeries in urology carried out in Bern

One procedure aimed to remove localized cancers (radical prostatectomy), another treated an enlarged prostate gland (Millin’s prostatectomy). A radical prostatectomy entails the removal of the entire prostate gland and attached seminal vesicles. ...

ByDistalmotion SA


Blue Earth Diagnostics Highlights Presentations on Axumin® (Fluciclovine F 18) and 18F-Fluciclovine at Upcoming ASTRO Annual Meeting

Blue Earth Diagnostics Highlights Presentations on Axumin® (Fluciclovine F 18) and 18F-Fluciclovine at Upcoming ASTRO Annual Meeting

.: 2532 Category: Genitourinary Cancer Title: Randomized Trial of Conventional vs Conventional plus Fluciclovine (18F) PET/CT-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer: Volumetric and Patient-Reported Toxicity Analyses Presenter: Vishal Ramesh Dhere, MD, Winship Cancer Institute, Department of Radiation Oncology, Emory University, Atlanta, Ga. ...

ByBlue Earth Diagnostics


Blue Earth Diagnostics Announces Key Results from Phase 3 SPOTLIGHT Study of iaF-rhPSMA-7.3, an Investigational PET Imaging Agent, in Biochemical Recurrence of Prostate Cancer

Blue Earth Diagnostics Announces Key Results from Phase 3 SPOTLIGHT Study of iaF-rhPSMA-7.3, an Investigational PET Imaging Agent, in Biochemical Recurrence of Prostate Cancer

When stratified by PSA level, the DRs in the 305 patients with prior prostatectomy were: PSA0.5 and1 and2 and5 and10 ng/mL: 100% (13/13). The study was designed to confirm positive F-rhPSMA-7.3 PET imaging findings using a composite Standard of Truth (SoT) consisting of either: histopathology (considered the gold standard); or conventional imaging (primarily with CT, bone scan ...

ByBlue Earth Diagnostics


Versius launched in Poland as CMR expands presence across region

Versius launched in Poland as CMR expands presence across region

” At Salve, Versius is currently being used across a range of urological procedures, including radical prostatectomies. The introduction of Versius in Poland follows CMR’s expansion into a number of markets across Europe, Middle East, India and Australia where the system is being used to perform surgical procedures across a range of surgical specialities including ...

ByCMR Surgical Ltd


Versius adopted for urological procedures in Pakistan

Versius adopted for urological procedures in Pakistan

Completing over 100 cases within two months, SIUT have rapidly integrated Versius into high-volume complex urological procedures, including cystectomies, prostatectomies and radical nephrectomies. Versius will be used as part of a multispecialty robotics programme, later being used for a range of general surgery procedures, including cholecystectomies and hernia repairs. ...

ByCMR Surgical Ltd


Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy

Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy

CAPTAIN (A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants with Localized Prostate Cancer) is a prospective, multi-centre randomized controlled trial of 201 patients aimed at comparing the safety and efficacy of the TULSA procedure (performed with the TULSA-PRO® system) with radical prostatectomy (“RP”) in men with ...

ByProfound Medical Corp.


Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update

Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update

In May, a study was published which analyzed the outcomes of over 800 Senhance System procedures across multiple specialties including hernia repairs, cholecystectomies, and prostatectomies based on data from the Company’s real-world clinical data registry, TRUST. ...

ByAsensus Surgical US, Inc.


Versius adopted by Guy’s and St Thomas’ NHS Foundation Trust to improve access to robotic surgery in London

Versius adopted by Guy’s and St Thomas’ NHS Foundation Trust to improve access to robotic surgery in London

” The multi-specialty programme has begun in the established urology department, and the robot is already helping surgeons to perform complex cases, including the first robotic prostatectomy in the UK with Versius. In the future, patients having colorectal and general surgeries at the Trust will also be able to benefit from robotic surgery with Versius. ...

ByCMR Surgical Ltd


Beyond Death Valley: Medtech Veteran Breathes New Life into HIFU Company

Beyond Death Valley: Medtech Veteran Breathes New Life into HIFU Company

He compares HIFU to the early days of robotic surgery: “The HIFU market is still in its infancy, and Rhodes said it reminds him of his early days at Intuitive Surgical, when the Irvine, CA-based robotics company was focused on prostate cancer, specifically radical prostatectomy, which was also a very young market at the time.” EDAP survived medtech's notorious ...

ByEDAP TMS


Alume Biosciences Granted FDA Fast Track Designation of ALM-488 for Surgical Nerve Visualization

Alume Biosciences Granted FDA Fast Track Designation of ALM-488 for Surgical Nerve Visualization

Surgeries where nerves are potentially at risk include procedures in the skull base, head and neck, spine, and nerve sparing prostatectomy. In vivo studies also indicate that ALM-488 has adequate pharmacokinetic characteristics to support clinical utility for the labelling of ureters in urology, gynecology and lower abdominal surgical indications. ...

ByAlume Biosciences, Inc.


Cancer Targeted Technology Commences Phase I Clinica Trial of CTT1057, a Diagnostic Imaging Agent for Prostate Cancer

Cancer Targeted Technology Commences Phase I Clinica Trial of CTT1057, a Diagnostic Imaging Agent for Prostate Cancer

Twenty patients will be enrolled in parallel in two cohorts: Cohort A will enroll patients with prostate cancer prior to radical prostatectomy (N = 5) and Cohort B will enroll patients with evidence of metastatic castration-resistant prostate cancer (N = 15). ...

ByCancer Targeted Technology

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT